|
Name |
10-Norparvulenone
|
Molecular Formula | C12H14O5 | |
IUPAC Name* |
4,8-dihydroxy-7-(hydroxymethyl)-6-methoxy-3,4-dihydro-2H-naphthalen-1-one
|
|
SMILES |
COC1=C(C(=C2C(=O)CCC(C2=C1)O)O)CO
|
|
InChI |
InChI=1S/C12H14O5/c1-17-10-4-6-8(14)2-3-9(15)11(6)12(16)7(10)5-13/h4,8,13-14,16H,2-3,5H2,1H3
|
|
InChIKey |
NXSUIALRPVXVTA-UHFFFAOYSA-N
|
|
Synonyms |
10-Norparvulenone; 618104-32-8; 4,8-dihydroxy-7-(hydroxymethyl)-6-methoxy-3,4-dihydro-2H-naphthalen-1-one; 313661-79-9; 3,4-dihydro-4,8-dihydroxy-7-(hydroxymethyl)-6-methoxy-1(2H)-naphthalenone; (+/-)-10-Norparvulenone; MLS004711975; MEGxm0_000227; SCHEMBL16226779; ACon0_001069; ACon1_001421; CHEBI:181472; DTXSID201346895; BS-1501; NCGC00180523-01; SMR003474898; BRD-A00672869-001-01-1; NCGC00180523-02!4,8-dihydroxy-7-(hydroxymethyl)-6-methoxy-3,4-dihydro-2H-naphthalen-1-one
|
|
CAS | 618104-32-8 | |
PubChem CID | 9991774 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 238.24 | ALogp: | 0.2 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 87.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 17 | QED Weighted: | 0.723 |
Caco-2 Permeability: | -4.798 | MDCK Permeability: | 0.00000420 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.722 | 20% Bioavailability (F20%): | 0.213 |
30% Bioavailability (F30%): | 0.941 |
Blood-Brain-Barrier Penetration (BBB): | 0.077 | Plasma Protein Binding (PPB): | 68.22% |
Volume Distribution (VD): | 0.689 | Fu: | 28.67% |
CYP1A2-inhibitor: | 0.207 | CYP1A2-substrate: | 0.226 |
CYP2C19-inhibitor: | 0.02 | CYP2C19-substrate: | 0.297 |
CYP2C9-inhibitor: | 0.015 | CYP2C9-substrate: | 0.301 |
CYP2D6-inhibitor: | 0.039 | CYP2D6-substrate: | 0.294 |
CYP3A4-inhibitor: | 0.102 | CYP3A4-substrate: | 0.269 |
Clearance (CL): | 13.929 | Half-life (T1/2): | 0.755 |
hERG Blockers: | 0.022 | Human Hepatotoxicity (H-HT): | 0.14 |
Drug-inuced Liver Injury (DILI): | 0.732 | AMES Toxicity: | 0.512 |
Rat Oral Acute Toxicity: | 0.228 | Maximum Recommended Daily Dose: | 0.013 |
Skin Sensitization: | 0.875 | Carcinogencity: | 0.16 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.264 |
Respiratory Toxicity: | 0.282 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003146 | 0.804 | D0YH0N | 0.308 | ||||
ENC003553 | 0.673 | D07MGA | 0.289 | ||||
ENC002782 | 0.541 | D0J4IX | 0.271 | ||||
ENC002781 | 0.540 | D07MUN | 0.254 | ||||
ENC003360 | 0.500 | D09PJX | 0.250 | ||||
ENC003000 | 0.500 | D02LZB | 0.235 | ||||
ENC005719 | 0.500 | D07MEH | 0.233 | ||||
ENC004189 | 0.492 | D0E9CD | 0.226 | ||||
ENC002458 | 0.491 | D09DHY | 0.223 | ||||
ENC004895 | 0.433 | D0C9XJ | 0.216 |